Latest News & Updates

Breaking News

  • 1 day ago

  • Simantini Singh Deo

Immuthera Brings Together World’s Top Scientists On New Advisory Board To Advance Cutting-Edge Therapies For Diabetes And Immune Disorders
Breaking News
AB Science Secures Dual Regulatory Approvals From U.S. FDA And EMA To Advance Masitinib Into Phase 3 For Late-Stage Prostate Cancer

Simantini Singh Deo

Other trending news you may like to read

Immuthera Brings Together World’s Top Scientists On New Advisory Board To Advance Cutting-Edge Therapies For Diabetes And Immune Disorders

Immuthera and PolTREG appoint top diabetes and immunotherapy experts to new Scientific Advisory Board for Treg therapy development.

Simantini Singh Deo

Article

AB Science Secures Dual Regulatory Approvals From U.S. FDA And EMA To Advance Masitinib Into Phase 3 For Late-Stage Prostate Cancer

AB Science receives FDA and EMA clearance to launch Phase 3 trial of masitinib for biomarker-selected mCRPC patients.

Simantini Singh Deo

Article

Redefining Pharma Training: Rajesh Bhattacharjee Shares His Transformational Vision For Learning & Development At FDC Limited

FDC’s Rajesh Bhattacharjee shares his PAC model and vision for pharma training that drives business growth and employee retention.

Simantini Singh Deo

Article

Essential Pharma Strengthens Leadership Team With Appointment Of Industry Veterans Simon Ramsden And Rob Smith

Essential Pharma appoints Simon Ramsden as CFO and Rob Smith as CTO to strengthen growth and operational strategy.

Simantini Singh Deo

Article